Micah Maxwell, MD, PhD, is an Instructor in the Division of Pediatric Oncology. He completed the MD/PhD program at Johns Hopkins in 2012, followed by a three-year pediatric residency at the Children’s Hospital of Pittsburgh. In 2015, he returned to Johns Hopkins as a Pediatric Hematology-Oncology Fellow. He was Chief Fellow 2017-2018, and Pediatric Sarcoma Fellow from 2018-2019.
Dr. Maxwell’s research focuses on the metabolomics of pediatric solid tumors, particularly high-risk rhabdomyosarcoma and neuroblastoma, both of which continue to have poor outcomes despite highly aggressive treatment regimens. Metabolomics – the study of the tiniest biochemicals present in cells, tissues and body fluids, and the role they play in driving cancer development – offers a new approach to understanding and managing disease and holds great promise for future targeted therapies to treat cancers. Currently, Dr. Maxwell is applying this approach to neuroblastoma and rhabdomyosarcoma, and he is excited about the potential to harness the same techniques to identify new therapeutic options in other pediatric solid tumors as well. Additionally, he is working on an evidence-based protocol for addressing the nutritional needs of patients with high-risk neuroblastoma.